US 10543221
Beta-lactamase inhibitors, formulations, and uses thereof
granted A61KA61K31/407A61K31/665
Quick answer
US patent 10543221 (Beta-lactamase inhibitors, formulations, and uses thereof) held by The Regents of the University of California expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jan 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/407, A61K31/665, A61K31/675, A61K45/06